Make a difference bw aptt and pt from robbins

| Feature | PT (Prothrombin Time) | aPTT (Activated Partial Thromboplastin Time) |
|---|---|---|
| Pathway tested | Extrinsic + common pathway | Intrinsic + common pathway |
| Reagents added | Tissue thromboplastin (e.g., brain extract) + Ca²⁺ | Kaolin (or negatively charged particles like glass beads) + cephalin (platelet phospholipid substitute) + Ca²⁺ |
| How it works | Exogenous tissue factor initiates the extrinsic pathway | Kaolin activates contact-dependent factor XII; cephalin substitutes for platelet phospholipids |
| Factors assessed | VII, X, V, II (prothrombin), fibrinogen | XII, XI, IX, VIII, X, V, II (prothrombin), fibrinogen |
| Unique factor | Factor VII (only detected by PT, not aPTT) | Factors VIII, IX, XI, XII (only detected by aPTT, not PT) |
| Common pathway factors | X, V, II, fibrinogen | X, V, II, fibrinogen |
| What prolongs it | Deficiency/dysfunction of factor V, VII, X, prothrombin, or fibrinogen | Deficiency/dysfunction of factors V, VIII, IX, X, XI, XII, prothrombin, fibrinogen, OR antiphospholipid antibodies |
| Clinical use / drug monitoring | Warfarin (coumadin) monitoring - warfarin blocks vitamin K-dependent factors (II, VII, IX, X) but PT is more sensitive because factor VII has the shortest half-life | Heparin monitoring (heparin potentiates antithrombin III, which inhibits thrombin and Xa) |
| Expressed as | Seconds; also reported as INR (International Normalized Ratio) for standardization | Seconds |
| Liver disease | Prolonged (liver makes most clotting factors; PT/PTT both used as markers of hepatocyte synthetic function) | Prolonged |
Source: Robbins, Cotran & Kumar Pathologic Basis of Disease, Chapter 4 (Coagulation Cascade, p.122) and Chapter 14 (Bleeding Disorders, p.619).